Aim: Early enteral nutrition is often recommended for patients with acute stroke who have difficulty with oral intake. This study aimed to develop a predictive model to assess the need for enteral nutrition in older patients with acute cerebrovascular disorders. The model employs a machine learning algorithm using observational parameters related to swallowing ability. Methods: Ninety patients experiencing a cerebrovascular accident for the first time were included in this study. Swallowing function was assessed using the Food Intake LEVEL Scale. Nine specific variables were used to create a model for determining the need for enteral nutrition. Initially, variable selection was conducted through correlation analysis. Subsequently, the data were randomly divided into training and test groups. Five machine learning methods were applied to identify the most effective algorithm: logistic regression, decision tree, random forest, support vector machine, and XG Boost. Results: Through correlation analysis, we identified the independent variables Functional Independence Measure, motor and cognitive scores and speech intelligibility. The logistic regression model demonstrated high performance (accuracy, 0.82; area under the curve, 0.82). Conclusion: We demonstrated that a predictive model, employing machine learning and integrating Functional Independence Measure motor and cognitive scores and speech intelligibility, exhibits superior predictive efficacy and ascertains the necessity for enteral nutrition. This model can be expediently appraised even by individuals not specialized in dysphagia. Additionally, it is applicable to patients who are incapable of adhering to conventional swallowing assessment protocols owing to compromised consciousness or cognitive impairments, or those with an exceptionally elevated risk of aspiration.

The authors have declared no competing interest.

This study did not receive any funding.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethical approval was obtained from the Clinical Research Ethics Committee of Kanazawa medical university hospital (approval number: 78), ensuring adherence to the Declaration of Helsinki.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

The data used to support the findings of this study are available from the corresponding author upon request.